- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 1.91M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $17.54M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $14.85M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.58M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.18M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $14.24M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $30.03M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $19.16M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $16.54M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $96.98M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $94.31M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 770.32K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$937.41K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $2.65M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $3.81M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$1.68 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$1.68 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $970.38K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $343.72K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.29M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.31M |